HOW COMMON IS WHOOPING-COUGH IN A NONVACCINATING COUNTRY

被引:31
作者
ISACSON, J
TROLLFORS, B
TARANGER, J
ZACKRISSON, G
LAGERGARD, T
机构
[1] GOTHENBURG UNIV,DEPT PEDIAT,S-41124 GOTHENBURG,SWEDEN
[2] GOTHENBURG UNIV,DEPT CLIN BACTERIOL,S-41124 GOTHENBURG,SWEDEN
[3] GOTHENBURG UNIV,DEPT MED MICROBIOL & IMMUNOL,S-41124 GOTHENBURG,SWEDEN
关键词
PERTUSSIS; INCIDENCE; ANTIBODIES; PERTUSSIS TOXIN; FILAMENTOUS HEMAGGLUTININ; PERTACTIN;
D O I
10.1097/00006454-199304000-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In Sweden general vaccination with a whole cell pertussis vaccine was recommended from 1953. In 1979 the recommendation was withdrawn because the Swedish-made vaccine had become ineffective. In order to determine the incidence of the disease in a nonvaccinating country, 400 children born in 1980 were randomly selected from the population register of Goteborg, Sweden. The parents of the children were interviewed in 1990, when the children were 10 years old. The parents of 377 children could be reached, and of those 372 were not vaccinated against pertussis. Of the nonvaccinated children 61% had experienced clinically typical whooping cough; 195 (119 with and 76 without a history of whooping cough) agreed to donate a serum sample for determination of antibodies against pertussis toxin, filamentous hemagglutinin and pertactin. Of the children with a history of whooping cough, 91% had antibodies against pertussis toxin, as had 64% of the children without a history of disease. All but 3 children had antibodies against filamentous hemagglutinin and all 195 children had antibodies against pertactin. The antibody titers against the 2 last mentioned proteins did not differ between children with and without a history of whooping cough or between children with and without antibodies against pertussis toxin.
引用
收藏
页码:284 / 288
页数:5
相关论文
共 18 条
[1]   BORDETELLA-PARAPERTUSSIS AND BORDETELLA-BRONCHISEPTICA CONTAIN TRANSCRIPTIONALLY SILENT PERTUSSIS TOXIN GENES [J].
ARICO, B ;
RAPPUOLI, R .
JOURNAL OF BACTERIOLOGY, 1987, 169 (06) :2847-2853
[2]  
BINKIN NJ, 1992, PEDIATR INFECT DIS J, V11, P653
[3]  
CHARLES IG, 1990, DHHS FDA901164 US PU, P136
[4]  
GIAMMANCO A, 1991, REV INFECT DIS, V13, P1216
[5]   DETECTION OF ANTIBODIES IN HUMAN-SERUM AGAINST THE FIMBRIAL HEMAGGLUTININ OF BORDETELLA-PERTUSSIS BY ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].
GRANSTROM, M ;
LINDBERG, AA ;
ASKELOF, P ;
HEDERSTEDT, B .
JOURNAL OF MEDICAL MICROBIOLOGY, 1982, 15 (01) :85-96
[6]  
IRONS LI, 1983, J GEN MICROBIOL, V129, P2769
[7]   ESTIMATING INCIDENCE OF WHOOPING-COUGH OVER TIME - A CROSS-SECTIONAL RECALL STUDY OF 4 SWEDISH BIRTH COHORTS [J].
KRANTZ, I ;
TARANGER, J ;
TROLLFORS, B .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1989, 18 (04) :959-963
[8]  
LAUTROP H, 1971, LANCET, V1, P1195
[9]   NUCLEOTIDE-SEQUENCE HOMOLOGY TO PERTUSSIS TOXIN GENE IN BORDETELLA-BRONCHISEPTICA AND BORDETELLA-PARAPERTUSSIS [J].
MARCHITTO, KS ;
SMITH, SG ;
LOCHT, C ;
KEITH, JM .
INFECTION AND IMMUNITY, 1987, 55 (03) :497-501
[10]  
MARK A, 1991, EUR J EPIDEMIOL, V7, P121, DOI 10.1007/BF00237354